Table 2 |
||||
|
Sensitivity and specificity of anti-citrullinated fibronectin antibodies. |
||||
|
Patient group |
n |
anti-FN-Cit1035,1036 positive |
sensitivity (%) |
specificity (%) |
|
|
||||
|
established RAa |
82 |
41 |
50.0 |
|
|
early RAa |
278 |
124 |
44.6 |
|
|
Controls |
186 |
3 |
1.6 |
98.4 |
|
non-RA |
154 |
3 |
1.9 |
98.1 |
|
Healthy |
32 |
0 |
0 |
100 |
|
|
||||
|
a Based upon CCP2-positive sera |
||||
|
van Beers et al. Arthritis Research & Therapy 2012 14:R35 doi:10.1186/ar3744 |
||||
